Andrew J. Wang

Array ( [id] => 1451297 [patent_doc_number] => 06455674 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Hypoxia-regulated genes' [patent_app_type] => B1 [patent_app_number] => 09/604978 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17370 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455674.pdf [firstpage_image] =>[orig_patent_app_number] => 09604978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383020 [patent_doc_number] => 06555667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Hypoxia-regulated genes' [patent_app_type] => B1 [patent_app_number] => 09/604728 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17379 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555667.pdf [firstpage_image] =>[orig_patent_app_number] => 09604728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440600 [patent_doc_number] => 06495675 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Pharmaceutical composition for treating or preventing influenza, and novel capped oligonucleotide' [patent_app_type] => B1 [patent_app_number] => 09/603378 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6831 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495675.pdf [firstpage_image] =>[orig_patent_app_number] => 09603378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559320 [patent_doc_number] => 06436644 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1)' [patent_app_type] => B1 [patent_app_number] => 09/589628 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6161 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436644.pdf [firstpage_image] =>[orig_patent_app_number] => 09589628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4302001 [patent_doc_number] => 06326152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => 1 [patent_app_number] => 9/587674 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15354 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326152.pdf [firstpage_image] =>[orig_patent_app_number] => 587674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559277 [patent_doc_number] => 06436634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => B1 [patent_app_number] => 09/587412 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14916 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436634.pdf [firstpage_image] =>[orig_patent_app_number] => 09587412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320695 [patent_doc_number] => 06331399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Antisense inhibition of tert expression' [patent_app_type] => 1 [patent_app_number] => 9/572423 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28845 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331399.pdf [firstpage_image] =>[orig_patent_app_number] => 572423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1542029 [patent_doc_number] => 06372433 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Antisense modulation of inhibitor of DNA binding-1 expression' [patent_app_type] => B1 [patent_app_number] => 09/561497 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25536 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372433.pdf [firstpage_image] =>[orig_patent_app_number] => 09561497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463226 [patent_doc_number] => 06350868 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Antisense human fucosyltransferase sequences and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/556031 [patent_app_country] => US [patent_app_date] => 2000-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 10894 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350868.pdf [firstpage_image] =>[orig_patent_app_number] => 09556031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507089 [patent_doc_number] => 06440723 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Arrays with modified oligonucleotide and polynucleotide compositions' [patent_app_type] => B1 [patent_app_number] => 09/528404 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16158 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440723.pdf [firstpage_image] =>[orig_patent_app_number] => 09528404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290318 [patent_doc_number] => 06180353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Antisense modulation of daxx expression' [patent_app_type] => 1 [patent_app_number] => 9/490692 [patent_app_country] => US [patent_app_date] => 2000-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24403 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180353.pdf [firstpage_image] =>[orig_patent_app_number] => 490692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301219 [patent_doc_number] => 06187545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Antisense modulation of pepck-cytosolic expression' [patent_app_type] => 1 [patent_app_number] => 9/488671 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24670 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187545.pdf [firstpage_image] =>[orig_patent_app_number] => 488671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4285115 [patent_doc_number] => 06268151 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Antisense modulation of macrophage migration inhibitory factor expression' [patent_app_type] => 1 [patent_app_number] => 9/489869 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28567 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268151.pdf [firstpage_image] =>[orig_patent_app_number] => 489869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383112 [patent_doc_number] => 06277832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Growth inhibitor for leukemia cells comprising antisense oligonucleotide derivative to wilms tumor gene (wt1)' [patent_app_type] => 1 [patent_app_number] => 9/487874 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 5040 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277832.pdf [firstpage_image] =>[orig_patent_app_number] => 487874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181474 [patent_doc_number] => 06159697 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Antisense modulation of Smad7 expression' [patent_app_type] => 1 [patent_app_number] => 9/487444 [patent_app_country] => US [patent_app_date] => 2000-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26762 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159697.pdf [firstpage_image] =>[orig_patent_app_number] => 487444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154350 [patent_doc_number] => 06156518 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Methods of using DNA encoding human alpha 1 adrenergic receptors' [patent_app_type] => 1 [patent_app_number] => 9/474551 [patent_app_country] => US [patent_app_date] => 1999-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 33386 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156518.pdf [firstpage_image] =>[orig_patent_app_number] => 474551 [rel_patent_id] =>[rel_patent_doc_number] =>)